Overview

LOSS- Louisiana Obese Subjects Study

Status:
Terminated
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
LOSS is a pragmatic clinical evaluation of intensive medical approaches to weight loss for individuals with extreme obesity (body mass index [BMI] 40-60 kg/m2). The intensive medical treatment is designed to produce 25% weight loss from baseline and to maintain at least 20% weight loss from baseline. The intensive medical treatment is compared to a usual care treatment model where individuals utilize self directed approaches to weight loss. The active treatment period is three years, followed by two years of observation.
Phase:
Phase 4
Details
Lead Sponsor:
Pennington Biomedical Research Center
Collaborator:
Louisiana Office of Group Benefits
Treatments:
Diethylpropion
Orlistat
Sibutramine